Literature DB >> 22045657

Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.

Muhammad Zahid1, Muhammad Saeed, Li Yang, Cheryl Beseler, Eleanor Rogan, Ercole L Cavalieri.   

Abstract

The neurotransmitter dopamine is oxidized to its quinone (DA-Q), which at neutral pH undergoes intramolecular cyclization by 1,4-Michael addition, followed by oxidation to form leukochrome, then aminochrome, and finally neuromelanin. At lower pH, the amino group of DA is partially protonated, allowing the competitive intermolecular 1,4-Michael addition with nucleophiles in DNA to form the depurinating adducts, DA-6-N3Ade and DA-6-N7Gua. Catechol estrogen-3,4-quinones react by 1,4-Michael addition to form the depurinating 4-hydroxyestrone(estradiol)-1-N3Ade [4-OHE1(E2)-1-N3Ade] and 4-OHE1(E2)-1-N7Gua adducts, which are implicated in the initiation of breast and other human cancers. The effect of pH was studied by reacting tyrosinase-activated DA with DNA and measuring the formation of depurinating adducts. The most adducts were formed at pH 4, 5, and 6, and their level was nominal at pH 7 and 8. The N3Ade adduct depurinated instantaneously, but N7Gua had a half-life of 3 H. The slow loss of the N7Gua adduct is analogous to that observed in previous studies of natural and synthetic estrogens. The antioxidants N-acetylcysteine and resveratrol efficiently blocked formation of the DA-DNA adducts. Thus, slightly acidic conditions render competitive the reaction of DA-Q with DNA to form depurinating adducts. We hypothesize that formation of these adducts could lead to mutations that initiate Parkinson's disease. If so, use of N-acetylcysteine and resveratrol as dietary supplements may prevent initiation of this disease.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045657      PMCID: PMC4418631          DOI: 10.1002/iub.538

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  25 in total

1.  N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Authors:  Muhammad Zahid; Muhammad Saeed; Mohammed F Ali; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2010-05-31       Impact factor: 7.376

2.  The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.

Authors:  Muhammad Zahid; Ekta Kohli; Muhammad Saeed; Eleanor Rogan; Ercole Cavalieri
Journal:  Chem Res Toxicol       Date:  2006-01       Impact factor: 3.739

3.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol.

Authors:  L A Stivala; M Savio; F Carafoli; P Perucca; L Bianchi; G Maga; L Forti; U M Pagnoni; A Albini; E Prosperi; V Vannini
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

5.  Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats.

Authors:  Paula C Mailander; Jane L Meza; Sheila Higginbotham; Dhrubajyoti Chakravarti
Journal:  J Steroid Biochem Mol Biol       Date:  2006-09-18       Impact factor: 4.292

6.  Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.

Authors:  Thomas S Hnasko; Nao Chuhma; Hui Zhang; Germaine Y Goh; David Sulzer; Richard D Palmiter; Stephen Rayport; Robert H Edwards
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

Review 7.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

8.  Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens.

Authors:  Muhammad Saeed; Eleanor Rogan; Ercole Cavalieri
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

9.  Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.

Authors:  Muhammad Zahid; Nilesh W Gaikwad; Mohamed F Ali; Fang Lu; Muhammad Saeed; Li Yang; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2008-04-08       Impact factor: 7.376

10.  Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases.

Authors:  Ercole L Cavalieri; Kai-Ming Li; Narayanan Balu; Muhammad Saeed; Prabu Devanesan; Sheila Higginbotham; John Zhao; Michael L Gross; Eleanor G Rogan
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

View more
  12 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

Review 3.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

4.  Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.

Authors:  Hyo Jin Son; Ji Hyun Choi; Ji Ae Lee; Dong Jin Kim; Kye Jung Shin; Onyou Hwang
Journal:  J Mol Neurosci       Date:  2015-02-22       Impact factor: 3.444

5.  Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease.

Authors:  Nilesh W Gaikwad; Daniel Murman; Cheryl L Beseler; Muhammad Zahid; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Biomarkers       Date:  2011-06-21       Impact factor: 2.658

Review 6.  Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  J Steroid Biochem Mol Biol       Date:  2011-03-21       Impact factor: 4.292

Review 7.  Plant-derived neuroprotective agents in Parkinson's disease.

Authors:  Wenyu Fu; Wenxin Zhuang; Shuanhu Zhou; Xin Wang
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

Review 8.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

9.  Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects.

Authors:  Judy L Bolton; Tareisha Dunlap
Journal:  Chem Res Toxicol       Date:  2016-09-29       Impact factor: 3.739

Review 10.  Chemical Reactivities of ortho-Quinones Produced in Living Organisms: Fate of Quinonoid Products Formed by Tyrosinase and Phenoloxidase Action on Phenols and Catechols.

Authors:  Shosuke Ito; Manickam Sugumaran; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.